Drug Profile
Research programme: bacterial vaccines - Astrogenetix
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Astrogenetix
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Candidiasis; Enterococcal infections; Klebsiella infections; Listeria infections; Proteus infections; Pseudomonal infections; Salmonella infections; Staphylococcal infections; Streptococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Salmonella-infections in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Candidiasis in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Enterococcal-infections in USA (Parenteral)